Growth hormone secretagogue actions on the pituitary gland: Multiple receptors for multiple ligands?

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 5-6, 2000, Pages 323-329

  Chen, Chen ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

cAMP; Growth hormone secretagogue; Growth hormone releasing hormone; Growth hormone releasing peptides; Ion channel; Phospholipase C; Pituitary; Protein kinase C; Somatotropes

Indexed keywords

CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PHOSPHOLIPASE C; PRALMORELIN; PROTEIN KINASE; PROTEIN KINASE C; SOMATOSTATIN;

CALCIUM CELL LEVEL; CHANNEL GATING; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HYPOPHYSIS; HYPOTHALAMUS; MOLECULAR CLONING; MOLECULAR INTERACTION; NONHUMAN; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CYCLIC AMP; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; ION CHANNELS; PITUITARY GLAND; PROTEIN KINASE C; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SOMATOSTATIN;

EID: 0034108356     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03258.x     Document Type: Review

References (63)

1. 1. Bowers CY, Momany FA, Reynolds GA et al. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1984; 106: 663-7.
2. 2. Momany FA, Bowers CY, Reynolds GA et al. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 1984; 114: 1531-6.
3. 3. Bowers CY, Sartor AA, Reynolds DG, Badger TAM. On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology 1991; 128: 2027-35.
4. 4. Chen C, Wu D, Clarke IJ. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 1996; 148: 381-6.
5. 5. Howard AD, Feighner SD, Cully DF et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-7.
6. 6. Leong DA, Pomes A, Veldhuis JD, Clarke IJ. A novel hypothalamic hormone measured in hypophyseal portal plasma drives rapid bursts of GH secretion. In: Proceedings of the US Endocrine Society Conference, 24-27 June 1998, New Orleans, LA, USA. The Endocrine Society, 1998; 64 (Abstract).
7. 7. Brazeau P, Vale W, Burgus R et al. Hypothalamic peptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 197: 77-9.
8. 8. Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982; 300: 276-8.
9. 9. Guillemin R, Brazeau P, Bohlen P et al. Growth hormone-releasing factor from a human pancreatic tumour that caused acromegaly. Science 1982; 218: 585-7.
10. 10. Tannenbaum GS, Ling N. The interrelationship between growth hormone (GH)-releasing factor and somatostatin in the generation of the ultradian rhythm of GH secretion. Endocrinology 1984; 115: 1952-57.
11. 11. Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysical-portal circulation of the rat. Science 1985; 230: 461-3.
12. 12. Frohman LA, Downs TR, Clarke IJ, Thomas GB. Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthetized sheep: Spontaneous secretion and response to insulin-induced hypoglycemia. J. Clin. Invest. 1990; 86: 17-24.
13. 13. Thomas GB, Cummins JT, Francis H et al. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocrinology 1991; 128: 1151-8.
14. 14. Mangan E, Cataldi M, Guillaume V et al. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep. Endocrinology 1994; 134: 562-7.
15. 15. Wu D, Chen C, Zhang J et al. Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture. J. Neuroendocrinol. 1994; 6: 185-90.
16. 16. Wu D, Chen C, Katoh K et al. The effect of GH-releasing peptide-2 (GHRP-2 or KP102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J. Endocrinol. 1994; 140: R9-13.
17. 17. Thorner MO, Hartman ML, Gaylinn BD et al. Current status of therapy with growth hormone-releasing neuropeptides. In: Savage MO, Bourguignon J, Grossman AB (eds). Frontiers in Paediatric Neuroendocrinology. Blackwell Science, Oxford. 1994; 161-7.
18. 2 on growth hormone (GH)-releasing factor stimulated GH release and intracellular adenosine 3′,5′-monophosphate acid accumulation in rat pituitary cell culture. Endocrinology 1989; 124: 2791-8.
19. 19. Pong SS, Chaung LY, Dean DC et al. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 1996; 10: 57-61.
20. 20. Lei T, Buchfelder M, Fahlbusch R, Adams EF. Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells. J. Mol. Endocrinol. 1995; 14: 135-8.
21. 21. Adams EF, Petersen B, Lei T et al. The growth hormone secretagogue, L-692 429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem. Biophys. Res. Commun. 1995; 208: 555-61.
22. 22. Wu D, Chen C, Clarke IJ. The effect of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J. Endocrinol. 1996; 14: 197-205.
23. 23. McKee KK, Palyha OC, Feighner SD et al. Molecular analysis of growth hormone secretagogue receptors (GHS-Rs): Cloning of rat pituitary and hypothalamic GHS-R type 1a cDNAs. Mol. Endocrinol. 1997; 11: 415-23.
24. 24. Chen C, Heyward P, Zhang J et al. Voltage-dependent potassium currents in ovine somatotrophs and their function in growth hormone secretion. Neuroendocrinology 1994; 59: 1-9.
25. 25. Feighner SD, Howard AD, Prendergast K et al. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 1998; 12: 137-45.
26. 26. Smith RG, Feighner S, Predergast K et al. A new orphan receptor involved in pulsatile growth hormone release. Trends Endocrinol. Metab. 1999; 10: 128-35.
27. 27. Lau YS, Camoratto AM, White LM, Moriarty CM. Effect of lead on TRH and GRF binding in rat anterior pituitary membranes. Toxicology 1991; 68: 169-79.
28. 28. Sethumadhaven K, Veeraragavan K, Bowers CY. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Biochem. Biophys. Res. Commun. 1991; 178: 31-7.
29. 29. Chen C, Farnworth P, Petersenn S et al. Growth hormone-releasing peptide-2 (GHRP-2) dose not act via the human growth hormone-releasing factor receptor in GC cells. Endocrine 1998; 9: 59-65.
30. 30. Tan CP, McKee KK, Liu Q et al. Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. Genomics 1998; 52: 223-9.
31. 31. Feighner SD, Tan CP, McKee KK et al. Receptor for motilin identified in the human gastrointestinal system. Science 1999; 284: 2184-8.
32. 32. Guan XM, Yu H, Palyha OC et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol. Brain Res. 1997; 48: 23-9.
33. 33. Chen C, Vincent JD, Clarke IJ. Ion channels and the signal transduction pathways in the regulation of growth hormone secretion. Trends Endocrinol. Metab. 1994; 5: 227-33.
34. 34. Chen C, Israel JM, Vincent JD. Electrophysiological responses to somatostatin of rat hypophysial cells in somatotroph-enriched primary cultures. J. Physiol. 1989; 408: 493-510.
35. 35. Chen C, Israel JM, Vincent JD. Electrophysiological responses of rat pituitary cells in somatotroph-enriched primary culture to human growth hormone-releasing factor. Neuroendocrinology 1989; 50: 679-87.
36. 36. Chen C, Zhang J, Vincent JD, Israel JM. Two types of voltage-dependent calcium currents in rat somatotrophs are reduced by somatostatin. J. Physiol. 1990; 425: 29-42.
37. 37. Chen C, Zhang J, McNeill P et al. Growth hormone releasing factor modulates calcium currents in human growth hormone secreting adenoma cells. Brain Res. 1992; 604: 345-8.
38. 2+ influx in the ovine somatotroph by growth hormone-releasing factor. Am. J. Physiol. 1995; 268: E204-12.
39. 1) and GH release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin. Endocrinology 1991; 128: 592-603.
40. 40. Herrington J, Hille B. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 1994; 135: 1100-8.
41. 41. Bresson-Bepoldin L, Dufy-Barbe L. GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs. Cell Calcium 1994; 15: 247-58.
42. 42. Katoh K, Chen C, Engler D. Effects of GHRP on GH release and intracellular calcium concentration in primary cultured ovine anterior pituitary cells. J. Reprod. Dev. 1996; 42 (Suppl.): 106-8.
43. 2) in rat anterior pituitary cells. Endocrinology 1993; 132: 1286-91.
44. 2+ permeability in cultured ovine somatotrophs. J. Neuroendocrinol. 1995; 7: 179-86.
45. 2) stimulates growth hormone secretion by depolarization in rat pituitary cell cultures. In: Proceedings of the 73rd Annual Meeting of the Endocrine Society, 19-22 June 1991, Washington, DC. The Endocrine Society, 1991; Abstract 230.
46. 46. Frohman LA, Downs TR, Chomczynski P. Regulation of growth hormone secretion. Front. Neuroendocrinol. 1992; 13: 344-405.
47. 47. Harwood JP, Grew C, Aguilera G. Action of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary. Mol. Cell. Endocrinol. 1984; 37: 277-84.
48. 48. Schonbrunn A. Somatostatin action in pituitary cells involves two independent transduction mechanisms. Metabolism 1990; 39 (Suppl. 2): 96-100.
49. 49. Wu D, Clarke IJ, Chen C. The role of protein kinase C in GH secretion induced by GH-releasing factor and GH-releasing peptides in cultured ovine somatotrophs. J. Endocrinol. 1997; 154: 219-30.
50. 50. Cheng K, Chan WW, Butler B et al. Stimulation of growth hormone release from rat primary pituitary cells by L-692 429, a novel non-peptidyl GH secretagogue. Endocrinology 1993; 132: 2729-31.
51. 2-induced growth hormone release from rat primary pituitary cells. Endocrinology 1991; 129: 3337-42.
52. 52. Cooper EMF, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 1995; 374: 421-4.
53. 53. Takai Y, Kaibuchi K, Sano K, Nishizuka Y. Counteraction of calcium-activated phospholipid-dependent protein kinase activation by adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in platelets. J. Biochem. 1982; 91: 403-6.
54. 54. Kaibuchi K,Takai Y, Ogawa Y et al. Inhibitory action of adenosine 3′,5′-monophosphate on phosphatidylinositol turnover: Difference in tissue response. Biochem. Biophys. Res. Commun. 1982; 104: 105-12.
55. 55. Mukhopadhyay AK, Schumacher M. Inhibition of hCG-stimulated adenylate cyclase in purified mouse Leydig cells by the phorbol ester PMA. FEBS Lett. 1985; 187: 56-60.
56. 56. Houslay MD. 'Cross-talk': A pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur. J. Biochem. 1991; 195: 9-27.
57. 57. Kelleher DJ, Pessin JE, Ruoho AE, Johnson GL. Phorbol ester induces desensitization of adenylate cyclase and phosphorylation of the β-adrenergic receptor in turkey erythrocytes. Proc. Natl Acad. Sci. USA 1984; 81: 4316-20.
58. 58. Kassis S, Zaremba T, Patel J, Fishman PH. Phorbol esters and beta-adrenergic agonists mediate desensitization of adenylate cyclase in rat glioma C6 cells by distinct mechanisms. J. Biol. Chem. 1985; 260: 8911-17.
59. 59. Sugden D, Vanecek J, Klein DC et al. Activation of protein kinase C potentiates isoprenaline-induced cyclic AMP accumulation in rat pinealocytes. Nature 1985; 314: 359-61.
60. 60. Cronin MJ, Canonico PL. Tumor promoters enhance basal and growth hormone releasing factor stimulated cyclic AMP levels in anterior pituitary cells. Biochem. Biophys. Res. Commun. 1985; 129: 404-10.
61. 61. Bell DJ, Buxton IL, Brunton LL. Enhancement of adenylate cyclase activity in S49 lymphoma cells by phorbol esters. Putative effect of C kinase on alpha s-GTP-catalytic subunit interaction. J. Biol. Chem. 1985; 260: 2625-8.
62. 62. Stevens CF, Sullivan JM. Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 1998; 21: 885-93.
63. 2+ by forskolin and phorbol ester. FEBS Lett. 1985; 183: 430-2.